Table of Contents

2019-2024 Global Antibiotic Resistance Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Antibiotic Resistance Consumption 2014-2024
  • 2.1.2 Antibiotic Resistance Consumption CAGR by Region
• 2.2 Antibiotic Resistance Segment by Type
  • 2.2.1 Urinary Tract Infection
  • 2.2.2 Intra-Abdominal Infections
  • 2.2.3 Blood Stream Infections
  • 2.2.4 Clostridium Difficile Infections
  • 2.2.5 Acute Bacterial Skin and Skin Structure Infections
  • 2.2.6 Bacterial Pneumonia
• 2.3 Antibiotic Resistance Consumption by Type
  • 2.3.1 Global Antibiotic Resistance Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Antibiotic Resistance Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Antibiotic Resistance Sale Price by Type (2014-2019)
• 2.4 Antibiotic Resistance Segment by Application
  • 2.4.1 Oxazolidinones
  • 2.4.2 Lipoglycopeptides
  • 2.4.3 Tetracyclines
  • 2.4.4 Cephalosporins
  • 2.4.5 Combination therapies
  • 2.4.6 Other
• 2.5 Antibiotic Resistance Consumption by Application
  • 2.5.1 Global Antibiotic Resistance Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Antibiotic Resistance Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Antibiotic Resistance Sale Price by Application (2014-2019)

3 Global Antibiotic Resistance by Manufacturers

• 3.1 Global Antibiotic Resistance Sales Market Share by Manufacturers
  • 3.1.1 Global Antibiotic Resistance Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Antibiotic Resistance Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Antibiotic Resistance Revenue Market Share by Manufacturers
  • 3.2.1 Global Antibiotic Resistance Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Antibiotic Resistance Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Antibiotic Resistance Sale Price by Manufacturers
• 3.4 Global Antibiotic Resistance Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Antibiotic Resistance Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Antibiotic Resistance Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Antibiotic Resistance by Regions

• 4.1 Antibiotic Resistance by Regions
  • 4.1.1 Global Antibiotic Resistance Consumption by Regions
  • 4.1.2 Global Antibiotic Resistance Value by Regions
• 4.2 Americas Antibiotic Resistance Consumption Growth
• 4.3 APAC Antibiotic Resistance Consumption Growth
• 4.4 Europe Antibiotic Resistance Consumption Growth
• 4.5 Middle East & Africa Antibiotic Resistance Consumption Growth

5 Americas

• 5.1 Americas Antibiotic Resistance Consumption by Countries
  • 5.1.1 Americas Antibiotic Resistance Consumption by Countries (2014-2019)
  • 5.1.2 Americas Antibiotic Resistance Value by Countries (2014-2019)
• 5.2 Americas Antibiotic Resistance Consumption by Type
• 5.3 Americas Antibiotic Resistance Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Antibiotic Resistance Consumption by Countries
  • 6.1.1 APAC Antibiotic Resistance Consumption by Countries (2014-2019)
  • 6.1.2 APAC Antibiotic Resistance Value by Countries (2014-2019)
• 6.2 APAC Antibiotic Resistance Consumption by Type
• 6.3 APAC Antibiotic Resistance Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Antibiotic Resistance by Countries
  • 7.1.1 Europe Antibiotic Resistance Consumption by Countries (2014-2019)
  • 7.1.2 Europe Antibiotic Resistance Value by Countries (2014-2019)
• 7.2 Europe Antibiotic Resistance Consumption by Type
• 7.3 Europe Antibiotic Resistance Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Antibiotic Resistance by Countries
  • 8.1.1 Middle East & Africa Antibiotic Resistance Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Antibiotic Resistance Value by Countries (2014-2019)
• 8.2 Middle East & Africa Antibiotic Resistance Consumption by Type
• 8.3 Middle East & Africa Antibiotic Resistance Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Antibiotic Resistance Distributors
• 10.3 Antibiotic Resistance Customer

11 Global Antibiotic Resistance Market Forecast

• 11.1 Global Antibiotic Resistance Consumption Forecast (2019-2024)
• 11.2 Global Antibiotic Resistance Forecast by Regions
  • 11.2.1 Global Antibiotic Resistance Forecast by Regions (2019-2024)
  • 11.2.2 Global Antibiotic Resistance Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Antibiotic Resistance Forecast by Type
• 11.8 Global Antibiotic Resistance Forecast by Application

12 Key Players Analysis

• 12.1 Allergan
  • 12.1.1 Company Details
  • 12.1.2 Antibiotic Resistance Product Offered
  • 12.1.3 Allergan Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Allergan News
• 12.2 AmpliPhi Biosciences
  • 12.2.1 Company Details
  • 12.2.2 Antibiotic Resistance Product Offered
  • 12.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 AmpliPhi Biosciences News
• 12.3 BioVersys GmbH
  • 12.3.1 Company Details
  • 12.3.2 Antibiotic Resistance Product Offered
  • 12.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 BioVersys GmbH News
• 12.4 Macrolide Pharmaceuticals
  • 12.4.1 Company Details
  • 12.4.2 Antibiotic Resistance Product Offered
  • 12.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Macrolide Pharmaceuticals News
• 12.5 Melinta Therapeutics
  • 12.5.1 Company Details
  • 12.5.2 Antibiotic Resistance Product Offered
  • 12.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Melinta Therapeutics News
• 12.6 Merck
  • 12.6.1 Company Details
  • 12.6.2 Antibiotic Resistance Product Offered
  • 12.6.3 Merck Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Merck News
• 12.7 Nabriva Therapeutics
  • 12.7.1 Company Details
  • 12.7.2 Antibiotic Resistance Product Offered
  • 12.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Nabriva Therapeutics News
• 12.8 Nemesis Bioscience
  • 12.8.1 Company Details
  • 12.8.2 Antibiotic Resistance Product Offered
  • 12.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Nemesis Bioscience News
• 12.9 Phage Technologies S.A
  • 12.9.1 Company Details
  • 12.9.2 Antibiotic Resistance Product Offered
  • 12.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Phage Technologies S.A News
• 12.10 Tetraphase Pharmaceuticals
  • 12.10.1 Company Details
  • 12.10.2 Antibiotic Resistance Product Offered
  • 12.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Tetraphase Pharmaceuticals News
• 12.11 The Medicines Company
• 12.12 TPfizer
• 12.13 Westway Health

13 Research Findings and Conclusion

Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.

According to this study, over the next five years the Antibiotic Resistance market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antibiotic Resistance business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotic Resistance market by product type, application, key manufacturers and key regions and countries.

This study considers the Antibiotic Resistance value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Urinary Tract Infection
Intra-Abdominal Infections
Blood Stream Infections
Clostridium Difficile Infections
Acute Bacterial Skin and Skin Structure Infections
Bacterial Pneumonia
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Antibiotic Resistance consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Antibiotic Resistance market by identifying its various subsegments.
Focuses on the key global Antibiotic Resistance manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antibiotic Resistance with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antibiotic Resistance submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.